ArticleCancer research2021

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma.

Lenka Besse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.